Article
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51
25 Feb 2022
Abstract excerpt
Breast cancer (BC) is the second cause of cancer-related deceases in the worldwide female population. Despite the successful treatment advances, 25% of BC develops resistance to current therapeutic regimens, thereby remaining a major hurdle for patient management. Current therapies, targeting the molecular events underpinning the adaptive resistance, still require effort to improve BC treatment. Using BC sphere...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
